Michael Ferguson serves as the VP - Global Commercial Lead for Trepostinil Palmitil Inhalation Powder (TPIP) at Insmed Incorporated since September 2025. As a Founding Partner at GW Forever Partners and a Senior Commercial Executive Consultant at Fisheye Learning, Michael provides strategic commercial insights and mentorship to biotechnology clients. Previously, Michael held the position of EVP and Chief Commercial Officer at Abivax and Vice President at Arena Pharmaceuticals, overseeing global brand strategies and leading cross-functional launch preparedness for multiple therapies. Michael has extensive experience in commercial leadership roles at Takeda and Shire, with significant achievements in driving market strategies, launching products, and managing comprehensive marketing teams. Michael's educational background includes a B.S. in Finance from Penn State University, an MBA with a focus on Biotechnology and Pharmaceutical Emphasis, and various certifications in marketing and sales management.
This person is not in the org chart
This person is not in any teams
This person is not in any offices